scholarly article | Q13442814 |
P356 | DOI | 10.1097/QAD.0B013E3280114ED7 |
P698 | PubMed publication ID | 17148971 |
P50 | author | Alimuddin Zumla | Q4726678 |
Veronica Mulenga | Q114437735 | ||
Chifumbe Chintu | Q114437737 | ||
Darlington M Mwenya | Q114437802 | ||
James C L Mwansa | Q114437803 | ||
Frederick Sinyinza | Q114437826 | ||
CHAP Trial Team | Q114437827 | ||
Stephen H Gillespie | Q56394968 | ||
Andrew Nunn | Q56477292 | ||
Diana M Gibb | Q62738885 | ||
Deborah Ford | Q88441081 | ||
Ann Sarah Walker | Q90248231 | ||
Kennedy Lishimpi | Q101239811 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 77-84 | |
P577 | publication date | 2007-01-01 | |
P1433 | published in | AIDS | Q4651863 |
P1476 | title | Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children | |
P478 | volume | 21 |
Q53679268 | A man with unsuspected marine eosinophilic gastritis. |
Q34687538 | A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa |
Q37047864 | Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events |
Q28473645 | Bacterial disease and antimicrobial susceptibility patterns in HIV-infected, hospitalized children: a retrospective cohort study |
Q37498812 | Causes of morbidity among HIV-infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia |
Q53733974 | Co-trimoxazole for HIV-exposed uninfected infants. |
Q90181420 | Co-trimoxazole or multivitamin multimineral supplement for post-discharge outcomes after severe anaemia in African children: a randomised controlled trial |
Q46265061 | Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana |
Q38872771 | Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort |
Q35452458 | Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi |
Q35804683 | Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial |
Q33695680 | Growth among HIV-infected children receiving antiretroviral therapy in Dar es Salaam, Tanzania |
Q33650105 | Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer |
Q34212799 | Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the |
Q37548424 | HIV screening among TB patients and co-trimoxazole preventive therapy for TB/HIV patients in Addis Ababa: facility based descriptive study |
Q37021586 | HIV-related pulmonary disorders: practice issues. |
Q34296972 | Haemophilus influenzae type b conjugate vaccines - a South African perspective |
Q37662573 | Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines |
Q36597730 | Health care resource utilization in untreated HIV-infected children in a pediatric programme, Abidjan, Côte d'Ivoire, 2004-2009. |
Q35825690 | Health outcomes of HIV-exposed uninfected African infants |
Q33793347 | Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV. |
Q35096801 | Invasive bacterial co-infection in African children with Plasmodium falciparum malaria: a systematic review |
Q31133369 | Maintaining data integrity in a rural clinical trial |
Q33834841 | Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau |
Q37695745 | Morbidity and health care resource utilization in HIV-infected children after antiretroviral therapy initiation in Côte d'Ivoire, 2004-2009. |
Q24234778 | Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection |
Q37037065 | Role of intestinal mucosal integrity in HIV transmission to infants through breast-feeding: the BAN study |
Q37426497 | Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility |
Q35217416 | The effect of daily co-trimoxazole prophylaxis on natural development of antibody-mediated immunity against P. falciparum malaria infection in HIV-exposed uninfected Malawian children |
Q38330997 | The expanding role of co-trimoxazole in developing countries |
Q36416849 | Transfusion and Treatment of severe anaemia in African children (TRACT): a study protocol for a randomised controlled trial |
Q35548335 | Under-two child mortality according to maternal HIV status in Rwanda: assessing outcomes within the National PMTCT Program |